Study finds type 2 diabetes risk with growth hormone therapy

05/15/2011 | Reuters

Children who received growth hormone treatments had a more than eightfold increased risk of developing type 2 diabetes compared with a group of children in the general population, a study in the Journal of Clinical Endocrinology found. Growth hormone can interfere with insulin activity, but the study did not prove the therapy was responsible for the increased diabetes risk and further study is needed, the researchers said.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ